|
Principal Investigator |
|
William Dauer, M.D.
Assistant Professor of Neurology & Pharmacology
wtd3@columbia.edu
|
Washington University, St. Louis, 1990, M.D. |
|
|
|
Scientists |
|
Nathan D. Jorgensen, Ph.D.
Postdoctoral Research Scientist
nj2169@columbia.edu |
At Columbia since 2007.
University of Minnesota, Ph.D.
Saint John's University, B.A. |
Interested in the molecular basis of neurological disease. Currently studying how mutated LRRK2 causes Parkinson's disease. |
|
|
|
Hardy Rideout, Ph.D.
Associate Research Scientist
hr227@columbia.edu |
At Columbia since 1999.
Dalhousie University 1999, Ph.D.
Wilfrid Laurier Univ 1995, M.A. |
|
|
Yong Peng, Ph.D.
Associate Research Scientist
yp2204@columbia.edu |
At Columbia since 2007.
The Ohio State University 2002-2007, Postdoc and Research Associate
Sichuan University, China, 2002, Ph.D. |
Interested in elucidating role of LRRK2 regulatory factors and their role in
Parkinson's disease. |
|
|
|
|
Technicians |
|
|
Kana Tsukamoto
kt2217@columbia.edu |
University of West Florida, MS 2005
Kyoto Women's University, BA 2001 |
|
|
|
Graduate Students |
|
Cherry Cheng-Ying Ho
ch2187@columbia.edu |
In Pathology Ph.D Program since 2003.
National Taiwan University 2003. |
Research studies the role of leucine-rich repeat kinase 2 (LRRK2) and how its mutations causes Parkinson's disease. |
|
|
|
Connie Eunji Kim
ck2127@columbia.edu |
Joined the Dauer lab in 2004.
In Integrated Program at Columbia University.
Yonsei University, Seoul, Korea. |
Interested in the molecular pathway of torsinA protein. |
|
|
|
Lauren Tanabe
lmt2104@columbia.edu |
The Univ of Chicago 2003, B.A.
Student in Dept of Pharmacology. |
Utilizing an in vitro murine stem cell system to decipher the
molecular events underlying neuron specific nuclear envelope
abnormalities found in the homozygous torsinA mutant (and knockout)
state. |
|
|
Past Lab Members |
|
Rose Goodchild, Ph.D.
Assistant Professor at University of Tennessee, Knoxville
|
|
|
Back to Top
|
